Ecobot Earns 2022 EBJ Business Achievement Award 16-02-2023, 19:50

WISeKey Semiconductors Expands its North American Footprint 16-02-2023, 02:09

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability 3-09-2024, 19:00